The reluctance of health insurers is despite the predicted cost reductions due to the elimination of secondary diseases such as diabetes, knee problems, or psychological problems due to weight loss among millions of GLP 1 users
Since insulin cannot be given as an injection to patients without diabetes, the route of nasal application was chosen
Ez a gygyszer nem ajnlott, ha olyan slyos gyomor- vagy blproblmja van, ami a gyomor lassabb rlst eredmnyezi (gynevezett gasztroparzis), vagy ha gyulladsos blbetegsge van
Emerging evidence suggests that age-related inflammatory signaling may influence ovarian aging
A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Medical science monitor: international medical journal of experimental and clinical research 17.6 (2011): PI15
Are GLP-1 Drugs Safe for People With Heart Disease